Table 2 Characteristics of the imaging studies
From: Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis
Author | Study design | Country | Population | Type of Imaging | Total imaging performed | Anticoagulant prophylaxis | Indication for imaging | CUS screening |
|---|---|---|---|---|---|---|---|---|
Bompard [36] | Retrospective cohort | France | All underwent CTPA | CTPA | 135 PE: 32 No PE: 103 | Yes | Clinical suspicion | NR |
Chen [37] | Retrospective cohort | China | Inpatients underwent CTPA | CTPA | 25 PE: 10 No PE: 15 | NR | Clinical suspicion | No |
Franco-Lopez [38] | Retrospective cohort | Spain | Inpatients underwent CTPA | Angio CTs | 18 | NR | Increase in D-Dimer | No |
Grillet [39] | Retrospective cohort | France | Inpatients underwent CTPA | CT scan | All 100 PE: 23 No PE: 77 | NR | All severe cases | No |
Leonard-Lorant [40] | Retrospective cohort | France | All underwent CT | CTPA | 106 PE: 32 No PE: 74 | Yes, 46% | Clinical suspicion 63% Others 37% | No |
Poyiadji [41] | Retrospective cohort | USA | All underwent CTPA | CTPA | 328 PE:72 No PE: 256 | Yes, partial | NR | NR |
Marone [43] | Retrospective cohort | Italy | Inpatients underwent CUS Non-ICU | CUS | 30 | No | Clinical suspicion | Clinical suspicion |
Cattaneo [42] | Retrospective cohort | Italy | Inpatients underwent CUS Non-ICU | CUS | 64 | Yes | Screening | Yes, asymptomatic |